24.01
1.24%
0.29
전일 마감가:
$23.72
열려 있는:
$23.51
하루 거래량:
335.15K
Relative Volume:
0.64
시가총액:
$1.67B
수익:
$133.62M
순이익/손실:
$-177.37M
주가수익비율:
-11.22
EPS:
-2.14
순현금흐름:
$23.50M
1주 성능:
+2.19%
1개월 성능:
+13.92%
6개월 성능:
+1.03%
1년 성능:
+29.81%
Xencor Inc Stock (XNCR) Company Profile
명칭
Xencor Inc
전화
626-305-5900
주소
465 N. HALSTEAD ST., PASADENA, CA
XNCR을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
XNCR | 24.01 | 1.67B | 133.62M | -177.37M | 23.50M | -2.14 |
VRTX | 450.00 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 748.66 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 588.46 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 248.13 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 106.53 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-04-16 | 재확인 | BTIG Research | Buy |
2024-02-28 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2023-05-19 | 개시 | BofA Securities | Buy |
2022-12-06 | 개시 | Cowen | Outperform |
2022-10-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2022-09-21 | 개시 | JP Morgan | Overweight |
2022-07-06 | 재개 | Canaccord Genuity | Buy |
2022-02-11 | 개시 | BMO Capital Markets | Outperform |
2022-01-21 | 개시 | SMBC Nikko | Outperform |
2021-12-15 | 개시 | H.C. Wainwright | Buy |
2021-10-15 | 재개 | BTIG Research | Buy |
2021-02-24 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2020-03-04 | 개시 | Barclays | Underweight |
2020-02-25 | 업그레이드 | Guggenheim | Neutral → Buy |
2020-01-30 | 개시 | RBC Capital Mkts | Outperform |
2019-11-20 | 재개 | Guggenheim | Neutral |
2019-08-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
2019-08-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
2019-06-13 | 개시 | Mizuho | Buy |
2019-04-12 | 개시 | Guggenheim | Buy |
2019-03-27 | 개시 | Berenberg | Buy |
2019-03-15 | 개시 | Raymond James | Outperform |
2018-09-10 | 재개 | BTIG Research | Buy |
2018-03-28 | 재개 | Leerink Partners | Outperform |
2017-03-02 | 개시 | Instinet | Neutral |
2017-03-02 | 재확인 | Wedbush | Outperform |
2016-10-04 | 개시 | Piper Jaffray | Overweight |
2015-12-22 | 개시 | Canaccord Genuity | Buy |
2015-08-05 | 재확인 | MLV & Co | Buy |
2015-02-12 | 재확인 | Oppenheimer | Outperform |
2015-01-28 | 재확인 | MLV & Co | Buy |
2014-07-11 | 개시 | Oppenheimer | Outperform |
모두보기
Xencor Inc 주식(XNCR)의 최신 뉴스
Principal Financial Group Inc. Sells 15,251 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor Reports Q3 2024 Earnings and Program Updates - TipRanks
Xencor (XNCR)'s Technical Outlook is Bright After Key Golden Cross - MSN
Wall Street Analysts Believe Xencor (XNCR) Could Rally 53.53%: Here's is How to Trade - MSN
Xencor, Inc. (NASDAQ:XNCR) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Xencor, Inc. (NASDAQ:XNCR) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
(XNCR) Proactive Strategies - Stock Traders Daily
EcoR1 Capital, LLC Increases Stake in Xencor Inc - GuruFocus.com
US Bancorp DE Reduces Stock Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor CEO Dahiyat Bassil sells shares worth $80,841 - Investing.com
Xencor executive sells shares worth $1.6 million By Investing.com - Investing.com Australia
Xencor executive sells shares worth $1.6 million - Investing.com India
PRIMECAP Management Bolsters Stake in Xencor Inc - GuruFocus.com
Xencor's SWOT analysis: biotech stock faces pivotal year ahead - Investing.com
Xencor's SWOT analysis: biotech stock faces pivotal year ahead By Investing.com - Investing.com UK
Xencor, Inc. (NASDAQ:XNCR) Analysts Just Slashed Next Year's Revenue Estimates By 14% - Yahoo Finance UK
Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Creative Planning - Defense World
Xencor’s (XNCR) “Outperform” Rating Reiterated at BMO Capital Markets - Defense World
Xencor (NASDAQ:XNCR) Given New $28.00 Price Target at JPMorgan Chase & Co. - Defense World
Xencor (NASDAQ:XNCR) Given Outperform Rating at Wedbush - Defense World
What is Wedbush’s Forecast for Xencor FY2024 Earnings? - Defense World
Leerink Partnrs Increases Earnings Estimates for Xencor - Defense World
Leerink Partnrs Brokers Lift Earnings Estimates for Xencor - MarketBeat
What is Wedbush's Forecast for Xencor FY2024 Earnings? - MarketBeat
Xencor, Inc. (NASDAQ:XNCR) Just Reported And Analysts Have Been Cutting Their Estimates - Simply Wall St
Xencor (NASDAQ:XNCR) Receives "Outperform" Rating from BMO Capital Markets - MarketBeat
Xencor shares target raised, rating held on pipeline progress By Investing.com - Investing.com Canada
Xencor shares target raised, rating held on pipeline progress - Investing.com
Xencor (NASDAQ:XNCR) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat
Xencor (NASDAQ:XNCR) shareholders are up 7.9% this past week, but still in the red over the last three years - Simply Wall St
Xencor Reports Third Quarter 2024 Financial Results - BioSpace
Xencor Inc earnings beat by $0.27, revenue fell short of estimates - Investing.com Canada
Xencor (XNCR) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Xencor: Q3 Earnings Snapshot - San Antonio Express-News
Trading (XNCR) With Integrated Risk Controls - Stock Traders Daily
Xencor Doses First Subject in Phase 1/2 Study of XmAb®942 in Development for Patients with Inflammatory Bowel Disease - BioSpace
Please Don’t Call Me a ‘Genus’: The High Bar for Section 112 in the Unpredictable Arts as Illustrated by In re Xencor - IPWatchdog.com
942 in Development for Patients with Inflammatory Bowel Disease - Business Wire
Does Xencor (XNCR) Have the Potential to Rally 68.16% as Wall Street Analysts Expect? - Yahoo Finance
Xencor (XNCR) Expected to Beat Earnings Estimates: Should You Buy? - MSN
Xencor, Inc. (NASDAQ:XNCR) Given Average Rating of "Buy" by Brokerages - MarketBeat
Xencor, Inc. (NASDAQ:XNCR) Given Average Rating of “Buy” by Analysts - Defense World
Xencor Inc (XNCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):